Literature DB >> 31238801

Effects of marked hypertriglyceridemia and lipid clearance techniques on canine biochemistry testing.

Carolina N Azevedo1,2, Jonathan A Lidbury1,2, Unity Jeffery1,2.   

Abstract

Triglyceride concentrations in dogs with hyperlipidemic disorders can exceed concentrations used by assay manufacturers for interference testing. High-speed centrifugation or the polar solvent LipoClear reduce triglyceride concentrations, but efficacy requires evaluation in veterinary species. We determined the effect of marked hypertriglyceridemia on canine biochemistry testing; assessed the ability of high-speed centrifugation or LipoClear to correct lipemic interferences; and determined if LipoClear introduces inaccuracy into biochemistry assays. Fifteen pooled canine serum samples were aliquoted and spiked with equal volumes of water or Intralipid [triglyceride concentration 33.9 mmol/L (3,000 mg/dL)]. Intralipid aliquots underwent lipid removal by high-speed centrifugation or LipoClear treatment, and a water-spiked aliquot underwent LipoClear treatment. Biochemistry panels were performed using a Vitros 4600 chemistry analyzer. Results were compared by paired t-test or Wilcoxon test. Total observed errors were considered clinically acceptable if below veterinary allowable total error (TEa) guidelines. Statistically significant (p ≤ 0.05) interferences were introduced by Intralipid for 15 of 15 analytes. Median observed error exceeded TEa for potassium and enzymatic carbon dioxide, neither of which were identified by the manufacturer as susceptible to lipemic interference. After centrifugation, median observed error exceeded TEa for potassium and chloride. LipoClear treatment resulted in median errors that exceeded TEa for total protein, chloride, and phosphorus. Given that severe lipemia can occur in dogs with primary or secondary hyperlipidemia, veterinary laboratories should perform their own interference testing at triglyceride concentrations relevant to their patient population and provide this information to clinicians to ensure optimal case management.

Entities:  

Keywords:  bias; centrifugation; interference; lipemia; quality improvement

Mesh:

Substances:

Year:  2019        PMID: 31238801      PMCID: PMC6857023          DOI: 10.1177/1040638719858690

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  32 in total

1.  Classifying laboratory incident reports to identify problems that jeopardize patient safety.

Authors:  Michael L Astion; Kaveh G Shojania; Tim R Hamill; Sara Kim; Valerie L Ng
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

2.  Cholesterol-based pericardial effusion and aortic thromboembolism in a 9-year-old mixed-breed dog with hypothyroidism.

Authors:  John M MacGregor; Elizabeth A Rozanski; Robert J McCarthy; Leslie C Sharkey; Matthew D Winter; Donald J Brown; John E Rush
Journal:  J Vet Intern Med       Date:  2004 May-Jun       Impact factor: 3.333

3.  ASVCP quality assurance guidelines: control of preanalytical, analytical, and postanalytical factors for urinalysis, cytology, and clinical chemistry in veterinary laboratories.

Authors:  Rebekah G Gunn-Christie; Bente Flatland; Kristen R Friedrichs; Balazs Szladovits; Kendal E Harr; Kristiina Ruotsalo; Joyce S Knoll; Heather L Wamsley; Kathy P Freeman
Journal:  Vet Clin Pathol       Date:  2012-03       Impact factor: 1.180

4.  Serum delipidation but not high-speed centrifugation is effective in clearing lipemia interference in serum lipase activity measurement.

Authors:  Vanja Radišić Biljak; Sandra Božičević; Maja Krhač; Andrea Radeljak; Marijana Vučić Lovrenčić
Journal:  Clin Chem Lab Med       Date:  2016-09-01       Impact factor: 3.694

5.  ASVCP guidelines: allowable total error guidelines for biochemistry.

Authors:  Kendal E Harr; Bente Flatland; Mary Nabity; Kathleen P Freeman
Journal:  Vet Clin Pathol       Date:  2013-12       Impact factor: 1.180

6.  Heterogeneity of manufacturers' declarations for lipemia interference--an urgent call for standardization.

Authors:  Nora Nikolac; Ana-Maria Simundic; Manuela Miksa; Gabriel Lima-Oliveira; Gian Luca Salvagno; Beatrice Caruso; Gian Cesare Guidi
Journal:  Clin Chim Acta       Date:  2013-08-24       Impact factor: 3.786

7.  Analytical and pre-analytical performance characteristics of a novel cartridge-type blood gas analyzer for point-of-care and laboratory testing.

Authors:  Matthijs Oyaert; Tom Van Maerken; Silke Bridts; Silvi Van Loon; Heleen Laverge; Veronique Stove
Journal:  Clin Biochem       Date:  2018-01-12       Impact factor: 3.281

Review 8.  Lipid metabolism and hyperlipidemia in dogs.

Authors:  Panagiotis G Xenoulis; Jörg M Steiner
Journal:  Vet J       Date:  2009-01-23       Impact factor: 2.688

9.  Ischemic necrosis of the digits and hyperlipidemia associated with atherosclerosis in a Miniature American Shepherd.

Authors:  Jessie Scaglione; Sandra F Diaz; John D Bonagura; Rebecca A Kohnken; Timothy H Helms; Rachel E Cianciolo
Journal:  J Am Vet Med Assoc       Date:  2018-07-15       Impact factor: 1.936

10.  Removing Lipemia in Serum/Plasma Samples: A Multicenter Study.

Authors:  María José Castro-Castro; Beatriz Candás-Estébanez; Margarita Esteban-Salán; Pilar Calmarza; Teresa Arrobas-Velilla; Carlos Romero-Román; Miguel Pocoví-Mieras; José Ángel Aguilar-Doreste
Journal:  Ann Lab Med       Date:  2018-11       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.